Cedars-Sinai Medical Center once again has been recognized by U.S. News & World Report as one of the best hospitals in the nation. The medical center ranked No. 8 nationally in the magazine's "Best Hospitals 2019-20" analysis, matching its rank from last year among a select group of 20 Honor Roll hospitals. Cedars-Sinai also ranked No. 2 in Southern California and No. 3 in the state.
Cedars-Sinai has joined the U.S.-United Arab Emirates Business Council to better provide care for patients traveling from the United Arab Emirates (UAE) for specialized care, and to develop stronger ties with private and public healthcare organizations in the Arabian Gulf region. The council will help Cedars-Sinai provide guidance and culturally appropriate care to Emirati patients, fostering better access to healthcare services that have helped Cedars-Sinai build a reputation as a global leader in patient care and research.
In 1976, Joel Geiderman, MD, decided he would take a leap of faith and specialize in a new area of medicine: emergency medicine. Now the co-chair of Cedars-Sinai's Ruth and Harry Roman Emergency Department discusses the transformative growth that has occurred in the specialty during the 40 years since it was officially established as a distinct area of patient care.
Cedars-Sinai is significantly increasing its financial support for safety-net organizations that serve people experiencing homelessness and others who are vulnerable. The institution is contributing $15 million to 108 nonprofit programs and organizations that foster housing stability, provide sustainable programs for homeless residents and build clinical and financial capacity at community clinics.
Over the last two decades, alumni of the Kerlan-Jobe Orthopaedic Clinic Sports Medicine Fellowship Program have played a significant leadership role in the nation's foremost sports medicine society. The legacy of the orthopaedic clinic continues this week with the installation of the fourth Kerlan-Jobe alumnus as president of the American Orthopaedic Society for Sports Medicine (AOSSM).
The Cedars-Sinai Accelerator is welcoming 11 health-tech companies from across the United States and Europe to its newest accelerator class. The companies are innovating solutions for a wide variety of healthcare challenges-from the way hospitals count inventory and schedule staffers to products such as a smart brace for knee replacement patients.
Cedars-Sinai has become a founding sponsor of Bioscience Los Angeles County, a new organization established to advance the pace of scientific innovation among major academic institutions, research hospitals, investors, companies, trade associations and public and quasi-public agencies across the region.
Every year, millions of Americans misuse or abuse prescription medications, sometimes leading to emergency room visits, addiction or even death. The problem has worsened amid the ongoing opioid crisis. To prevent drugs from falling into the wrong hands, it's more important than ever to dispose of unused pills in a safe and smart way -- and simply throwing them away or even flushing them down the toilet are actually very dangerous options.
As the opioid epidemic continues to claim lives and shatter families across the nation, a Cedars-Sinai expert is urging physicians and patients to try managing pain without the addictive pills. The news release below includes 5 tips for opioid-free pain management.
To survive in his struggle against an aggressive form of prostate cancer, Bin McLaurin didn't only have to overcome the disease attacking his body. He said he also had to toss out his long-held image of masculinity.
While many parents and children go into related lines of work, few do it with as much heart–literally–as a father-and-son duo at Cedars-Sinai. Fardad Esmailian, MD, transplants hearts. His 23-year-old son, Gabby Esmailian, is part of the crew that dashes around California and other states, procuring hearts, and sometimes lungs and livers, before delivering them to waiting Cedars-Sinai surgeons.
A new analysis conducted by investigators at the Cedars-Sinai Smidt Heart Institute shows for the first time that patients with a common heart defect who undergo catheter-based valve replacement procedures have the same survival and complication rates as patients without the defect who undergo the same procedure.
Scientists can't make a living copy of your brain outside your body. That's the stuff of science fiction. But in a new study, they recreated a critical brain component, the blood-brain barrier, that functioned as it would in the individual who provided the cells to make it.
The Cedars-Sinai Graduate School of Biomedical Sciences awarded a record number of advanced degrees at its 7th annual commencement, where a Nobel laureate urged the graduates to "tackle our greatest challenges" by sustaining their commitment to science despite political headwinds.
Cedars-Sinai has appointed Heather Renshaw Vucetin, a seasoned fundraising executive with two decades of experience in academic medicine, as vice president of Development.
Meditation techniques helped Gregory Rutchik make it through his stroke when he was just 51 years old. Now those techniques are helping him keep his cool while running marathons.
Just hours before Rebecca Woolf's 44-year-old husband died of pancreatic cancer, the melodic tones of a harp wafted into his hospital room. Rebecca describes the music as a gift. Cedars-Sinai’s long-running Music for Healing program dispatches musicians and singers to perform for patients and their loved ones. Most perform in patients’ rooms, but others play the piano in the Plaza Level Lobby.
Cedars-Sinai is pleased to announce the appointment of Nancy L. Sicotte, MD, as chair of the Department of Neurology.
A novel imaging technique that uses a synthesized form of scorpion venom to light up brain tumors has shown promise in a clinical trial. The imaging system enables neurosurgeons to better see malignant growths that often are difficult to fully eliminate. The new imaging technique that was studied uses a special high-sensitivity near-infrared camera developed at Cedars-Sinai, along with the imaging agent tozuleristide, or BLZ-100, developed by Blaze Bioscience, Inc.
Nothing can ruin foreign travel like a nasty virus. A small bug bite or even a sip of water can lead to a serious illness and wreck a long-planned vacation. But with a little planning and preparation, it's easy to protect your health. Specially trained pharmacists with Cedars-Sinai's Travel Medicine program have developed a "pre-flight" checklist for international travelers.
Cedars-Sinai volunteer Patricia Marquis, whose stage name is Patricia Magicia, uses magic for more than just entertainment. She uses her craft as a welcome distraction for patients facing an array of illnesses.
As death closed in on the Jews of the Warsaw Ghetto during World War II, some of those coping amid the wretched conditions affirmed life in an extraordinary way: They operated a clandestine medical school. For Leo A. Gordon, MD, a surgeon on the Cedars-Sinai staff for 40 years, the short-lived secret school endures as a source of inspiration, courage and defiance. But most of all, it is a story of the essence of education pitted against the essence of attempted cultural annihilation.
Children and older adults are considered to be at higher risk for contracting measles. In this advisory, Michael Ben-Aderet, MD, associate director of Hospital Epidemiology at Cedars-Sinai, shares what parents need to know about measles, including risk factors and tips for preventing it.
It was in the Boy Scouts, decades before he came to Cedars-Sinai, that Dr. Nicholas Nissen, surgical director of Liver Transplantation, learned about going above and beyond the call of duty. On Thursday, April 25, he will receive one of the highest honors bestowed by Scouts USA: The rank of Distinguished Eagle Scout.
After Hermine Honarvar Rule was told that she was in critical need of a kidney transplant, two relatives and a friend each volunteered to give up a kidney to help save her. But during the screening process all three candidates were discovered to have health issues that would disqualify them from donating. Thankfully, her husband Mark turned out to be the right match for his wife. “We were truly made for each other,” he jokes today.
Family physicians play a crucial role in mental healthcare, but many lack the specific training needed to help their patients. Cedars-Sinai aims to close that gap by funding a new yearlong psychiatry fellowship. Through a $650,000 grant, 30 Los Angeles-based primary care safety-net providers are taking part in the program, known as UC Irvine/UC Davis Train New Trainers Primary Care Psychiatry Fellowship.
Here's a great story about a Kentucky woman who donated a kidney to a perfect stranger from New York who 21 years earlier had undergone a heart-liver transplant. The two women met on the Matching Donors website, a non-profit organization that provides a platform where patients and potential donors can meet. All three organ transplants took place at Cedars-Sinai in Los Angeles.
Dan Theodorescu, MD, PhD, director of Cedars-Sinai Cancer and Phase ONE Foundation Distinguished Chair in Oncology, was introduced as a new member of the Association of American Physicians (AAP) at the group's annual meeting in Chicago on April 6.
A recent study found that nearly 18 percent of patients diagnosed with multiple sclerosis before being referred to two major Los Angeles medical centers for treatment actually had been misdiagnosed with the autoimmune disease. The investigators found that many patients who came to the medical centers with a previous diagnosis of MS did not fulfill the criteria for that diagnosis, and spent an average of four years being treated for MS before receiving a correct diagnosis.
A new study provides critical insight into a little-known, yet relatively common, inherited neurological condition called Charcot-Marie-Tooth disease. The findings point to a pathway to possible treatments for this disease and better understanding of other neurodegenerative disorders, including Alzheimer's disease, that affect millions.
For decades, many have considered aneurysms a death sentence, but thanks to innovative, minimally invasive procedures, many can be treated before they become critical. Simi Valley, Calif., resident Roxanne Hanks is living proof that aneurysms are not always deadly. Her own subtle yet persistent symptoms were in fact signs of an aortic aneurysm and led to early detection and treatment.
Cedars-Sinai is front and center in the growing trend of population health studies, which addresses environmental, cultural and genetic factors to understand why certain populations—groups defined by race, ethnicity and socioeconomic status—have higher rates of cancer and other diseases than other groups. In Los Angeles County and across California, the medical center's Health Equity team is focusing on the high cancer mortality rate among Korean-Americans and the growing incidence of liver cancer in the Hispanic population, in addition to other health disparities in a number of communities.
A protein associated with cancer growth appears to drive the deadly lung disease known as idiopathic pulmonary fibrosis, according to new research from Cedars-Sinai. The discovery, made in laboratory mice and human tissue samples, may have implications for treating the disease using existing anti-cancer therapies that inhibit the protein PD-L1.
Following an extensive national search, Cedars-Sinai has appointed David R. Marshall, JD, DNP, RN, CENP, NEA-BC, NHDP-BC, FAAN, as senior vice president and chief nursing executive. Marshall brings more than three decades of healthcare experience from bedside nurse to nursing-leadership proficiency and a reputation for enhancing innovation and emphasizing compassionate care.
Two of Southern California's leading nonprofit healthcare organizations have agreed to create a joint venture that will own and operate Providence Tarzana Medical Center. The medical center's new name will be Providence Cedars-Sinai Tarzana Medical Center.
Dr. Zab Mosenifar, 70, has run every day of his adult life -- mostly in the Santa Monica Mountains -- and racked up about 135,200 miles (the equivalent of 5.6 times around the Earth). This Saturday, he will run his 100th marathon -- the Catalina Island Marathon, rated the sixth toughest in the world.
The Clinical Research Forum recognized the Cedars-Sinai's Smidt Heart Institute with a 2019 Top Ten Clinical Research Achievement Award today for its study aimed at developing a blood pressure control program for African-American men in the comfortable and convenient environments of their barbershops. In just six short months, the study improved the outcomes and control of high blood pressure in more than 60 percent of participants.
A pilot program underway in more than 100 patient rooms at Cedars-Sinai is allowing patients to use an Alexa-powered platform known as Aiva to interact hands-free with nurses and control their entertainment. Aiva is the world's first patient-centered voice assistant platform for hospitals. In the pilot project, patient rooms are equipped with Amazon Echos and patients simply tell the device what they need.
EMBARGOED: A new study has identified a drug that potentially could make a common type of immunotherapy for cancer even more effective. The study in laboratory mice found that the drug dasatinib, which is FDA-approved to treat certain types of leukemia, greatly enhances responses to a form of immunotherapy that is used against a wide range of other cancers.
A new study has found that transplanting the bone marrow of young laboratory mice into old mice prevented cognitive decline in the old mice, preserving their memory and learning abilities. The findings support an emerging model that attributes cognitive decline, in part, to aging of blood cells, which are produced in bone marrow.
Maxwell and Mason are twins who were born prematurely, weighing just 2 pounds and 10 ounces each, and each with a hole in his heart. At two weeks of age, the brothers underwent a nonsurgical procedure to fix their hearts - a physician guided a catheter through a vein in the leg to the heart and closed the hole. The procedure took only a few minutes. Today, Maxwell and Mason are energetic and healthy 1-year-olds with no signs of premature birth or their congenital heart condition.
Patrick D. Lyden, MD, a world-renowned stroke expert who played a key role in the pivotal clinical trial leading to approval of the first proven stroke therapy, will receive the American Stroke Association’s prestigious William M. Feinberg Award for Excellence in Clinical Stroke.
It's no secret that wearable, pop culture tech devices like Fitbit can aid in achieving fitness and activity goals. Now, a new study shows that using Fitbit activity monitors to measure how many steps a patient takes in the days after surgery can predict which patients leave the hospital sooner.
New experimental cancer treatments are raising hopes among clinicians and patients for longer survival times and cures. But clinical trials that test such treatments also need to analyze the impact on patients of potentially harsh side effects, known as adverse events. A major new study now underway aims to better incorporate patient feedback into clinical trials that help determine which new cancer treatments will be approved for use.
A new study in the journal Gastroenterology reveals that the standard method for ranking patients on the waitlist for lifesaving liver transplantation may not prioritize some of the sickest candidates for the top of the list.
When patients fail to take prescribed medications—or don't use them the right way—they risk return trips to the hospital and cost the U.S. healthcare system more than $100 billion a year. Older hospital patients are most susceptible to drug-related problems that can lead to readmissions or even death. To help these individuals get the right medications and take them correctly after discharge, Cedars-Sinai has embedded pharmacists in the care teams treating certain high-risk patients. Medication lists are double-checked by a pharmacist for errors prior to discharge, and patients are sent home with their prescription drugs after being counseled on how to take them properly.
On what would have been his father’s 90th birthday, Martin Luther King III, the eldest son of the celebrated civil rights leader, addressed a capacity crowd in Cedars-Sinai's Harvey Morse Auditorium, taking them on a stirring journey through his childhood, his father's legacy and his vision for a united America. Downloadable video is available.
A special edition of National Geographic on "The Future of Medicine" highlights the innovative stem-cell science of Cedars-Sinai, showing how investigators are seeking to use stem cells and Organ-Chips to tailor personalized treatments for individual patients. Downloadable video available.
Cedars-Sinai Cancer drove major advances in cancer research in 2018. Among these was a study about a pancreatic cancer drug, Metavert, developed by Cedars-Sinai investigators to prevent the most common type of pancreatic cancer from growing and spreading. Other groundbreaking research this year focused on reducing health disparities, the latest treatment options for newly diagnosed melanoma patients, and a study outlining a new, more accurate system for assessing the severity of head and neck cancers and for predicting patient survival.
Physician-researchers at Cedars-Sinai are available to discuss neuroscience findings from 2018. Several are detailed in this news release, including a study that found prolonged exposure to particulate matter in air pollution can cause changes in the brain. These changes could make people more susceptible to cancer, Alzheimer's disease and other neurological disorders.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right